(19)
(11) EP 3 019 519 A1

(12)

(43) Date of publication:
18.05.2016 Bulletin 2016/20

(21) Application number: 14823321.6

(22) Date of filing: 10.07.2014
(51) International Patent Classification (IPC): 
C07K 14/31(2006.01)
C07K 1/22(2006.01)
B01D 15/38(2006.01)
C12N 15/00(2006.01)
(86) International application number:
PCT/SE2014/050882
(87) International publication number:
WO 2015/005862 (15.01.2015 Gazette 2015/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 10.07.2013 SE 1350859
10.07.2013 SE 1350860

(71) Applicant: GE Healthcare Bio-Sciences AB
75184 Uppsala (SE)

(72) Inventors:
  • RODRIGO, Gustav
    S-751 84 Uppsala (SE)
  • ANDER, Mats
    S-751 84 Uppsala (SE)
  • BAURÉN, Göran
    S-751 84 Uppsala (SE)
  • BJÖRKMAN, Tomas
    S-751 84 Uppsala (SE)

(74) Representative: Larsson, Jan Anders 
GE Healthcare Bio-Sciences AB Björkgatan 30
751 84 Uppsala
751 84 Uppsala (SE)

   


(54) MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES